3D Printing: A Case of ZipDose® Technology – World's First 3D Printing Platform to Obtain FDA Approval for a Pharmaceutical Product
Authors:
- 14 December 2018
- book chapter
- Published by Wiley
- p. 53-79
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- 3D printing of oral drugs: a new reality or hype?Expert Opinion on Drug Delivery, 2017
- A new chapter in pharmaceutical manufacturing: 3D-printed drug productsAdvanced Drug Delivery Reviews, 2017
- Additively manufactured medical products – the FDA perspective3D Printing in Medicine, 2016
- Randomized Comparative Bioavailability of a Novel Three-Dimensional Printed Fast-Melt Formulation of Levetiracetam Following the Administration of a Single 1000-mg Dose to Healthy Human Volunteers Under Fasting and Fed ConditionsDrugs in R&D, 2016
- 3D printing in pharmaceutics: A new tool for designing customized drug delivery systemsInternational Journal of Pharmaceutics, 2016
- Burden of uncontrolled epilepsy in patients requiring an emergency room visit or hospitalizationNeurology, 2012
- Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed EpilepsyJAMA, 2011
- Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care populationEpilepsia, 2007
- Evaluation of Critical Formulation Factors in the Development of a Rapidly Dispersing Captopril Oral Dosage FormDrug Development and Industrial Pharmacy, 2003
- Three Dimensional Printing: Rapid Tooling and Prototypes Directly from a CAD ModelJournal of Engineering for Industry, 1992